16.5
Bacterial Meningitis
View the full transcript and gain access to JoVE Core videos
Q1: How does Neisseria meningitidis attach to and cross the nasopharyngeal epithelium?
Neisseria meningitidis uses Type IV pili and outer membrane proteins to attach strongly to nasopharyngeal epithelial cells. Once anchored, the bacteria disrupt tight junctions between epithelial cells, compromising barrier integrity. This disruption allows bacteria to traverse the epithelial layer and enter the bloodstream, initiating infection.
Q2: What role does Lipid A play in bacterial meningitis pathogenesis?
Lipid A, a component of the lipooligosaccharide layer, is released by bacteria in outer membrane vesicles during bacteremia. Acting as an endotoxin, Lipid A stimulates a robust immune response characterized by cytokine release, inflammation, and vasodilation. While this inflammatory reaction contributes to disease symptoms, it also helps disseminate bacteria to the blood–brain barrier.
Q3: How do bacteria evade immune clearance and reach the central nervous system?
Some bacterial cells survive transiently within phagocytes like macrophages, evading immune clearance. These immune cells inadvertently transport bacteria to the blood–brain barrier during hematogenous dissemination. Specialized adhesins then facilitate bacterial attachment to endothelial cells, enabling penetration into the cerebrospinal fluid.
Q4: What are the common causative organisms of bacterial meningitis?
Common causative organisms include Neisseria meningitidis, a gram-negative aerobic diplococcus, along with Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The specific pathogen varies by patient age, immune status, and underlying conditions. Each organism employs distinct mechanisms to breach epithelial barriers and reach the meninges.
Q5: What is the primary route of bacterial dissemination to the meninges?
Hematogenous spread is the most common route, where bacteria colonize mucosal surfaces such as the nasopharynx, breach the epithelial barrier, and enter the bloodstream. From there, they cross the blood–brain barrier using specialized adhesins and invasins. This pathway accounts for the majority of bacterial meningitis cases.
Q6: What happens when bacteria penetrate the blood–brain barrier and enter the cerebrospinal fluid?
Once bacteria penetrate the blood–brain barrier using specialized adhesins, they multiply within the cerebrospinal fluid and trigger a strong inflammatory response. Immune cell recruitment and mediator release cause swelling of the meninges, resulting in characteristic symptoms including headache, fever, and neck stiffness.
Q7: How do encapsulated strains of Neisseria meningitidis contribute to meningococcal meningitis?
Encapsulated strains of Neisseria meningitidis are gram-negative, aerobic diplococci that are common causative agents of meningococcal meningitis. Their capsule and outer membrane proteins facilitate adhesion to epithelial cells and help evade immune recognition, similar to mechanisms seen in atypical pneumonia. These virulence factors enable the bacteria to establish infection and disseminate to the central nervous system.